Innovation in Early Detection

The rise of MASH (Metabolic Dysfunction-Associated Steatohepatitis) requires a proactive approach. At our booth, we showcased how iLivTouch provides a fast, non-invasive solution for identifying liver fibrosis and fatty change—empowering clinicians to intervene earlier and improve patient outcomes.

A Special Thank You

Our mission is fueled by collaboration. We want to extend our sincere gratitude to Dr. Geoff You and Wayne Miracle for their incredible dedication and leadership in educating the community on the clinical impact of iLivTouch and MASH awareness.